11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Rifampicin/Isoniazid/Pyrazinamide

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Isoniazid

Isoniazid

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Scheinhorn DJ, Angelillo VA. Antituberculous therapy in pregnancy. Risks to the fetus. West J Med 1977;127:195-8.

  2. Snider DE, Layde PM, Johnson MW et al. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980;122:65-79.

  3. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.

  4. Schaefer C, Peters P, Miller RK. Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press, Elsevier; 2015.

  1. Scheinhorn DJ, Angelillo VA. Antituberculous therapy in pregnancy. Risks to the fetus. West J Med 1977;127:195-8.
  2. Snider DE, Layde PM, Johnson MW et al. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980;122:65-79.
  3. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.
  4. Schaefer C, Peters P, Miller RK. Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment. Academic Press, Elsevier; 2015.
2 2
2 2

Rifampicin

Rifampicin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Steen JS, Stainton-Ellis DM. Rifampicin in pregnancy. Lancet 1977;2:604-5.

  2. Scheinhorn DJ, Angelillo VA. Antituberculous therapy in pregnancy. Risks to the fetus. West J Med 1977;127:195-8.

  3. Snider DE, Layde PM, Johnson MW et al. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980;122:65-79.

  4. Antituberculous drugs in pregnancy. Lancet 1980;2:1285-6.

  5. United Kingdom Teratology Information Services (UKTIS). Rifampicin in pregnancy. 2016. Tillgänglig från: www.toxbase.com. Hämtad 2018-07-23.

  1. Steen JS, Stainton-Ellis DM. Rifampicin in pregnancy. Lancet 1977;2:604-5.
  2. Scheinhorn DJ, Angelillo VA. Antituberculous therapy in pregnancy. Risks to the fetus. West J Med 1977;127:195-8.
  3. Snider DE, Layde PM, Johnson MW et al. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980;122:65-79.
  4. Antituberculous drugs in pregnancy. Lancet 1980;2:1285-6.
  5. United Kingdom Teratology Information Services (UKTIS). Rifampicin in pregnancy. 2016. Tillgänglig från: www.toxbase.com. Hämtad 2018-07-23.
2 2
2 2

Pyrazinamid

Pyrazinamid

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Jana N, Vasishta K, Saha SC, Ghosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med. 1999;341(9):645-9.

  2. Keskin N, Yilmaz S. Pregnancy and tuberculosis: to assess tuberculosis cases in pregnancy in a developing region retrospectively and two case reports. Arch Gynecol Obstet. 2008;278(5):451-5.

  3. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.

  1. Jana N, Vasishta K, Saha SC, Ghosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med. 1999;341(9):645-9.
  2. Keskin N, Yilmaz S. Pregnancy and tuberculosis: to assess tuberculosis cases in pregnancy in a developing region retrospectively and two case reports. Arch Gynecol Obstet. 2008;278(5):451-5.
  3. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.